Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples